Latest Impairments News

Page 3 of 98
Evergy delivered a stronger third quarter, lifted its 2026 adjusted earnings guidance and outlined new power commitments tied to large customers, including a proposed 1.4 GW Digital Realty expansion. The utility also increased its quarterly dividend by 4%.
Maxwell Dee
Maxwell Dee
5 Nov 2026
BD finished fiscal 2026 with higher revenue, adjusted earnings and cash generation, while setting low single-digit growth expectations for the year ahead. Its proposed US$19 billion US investment adds scale to the strategy, but remains tied to milestones and future implementation.
Ada Torres
Ada Torres
5 Nov 2026
Air Products delivered 12% growth in fiscal 2026 adjusted EPS and cut capital spending by US$1.8 billion, while absorbing another US$3.2 billion in charges tied mainly to project exits. The company expects further adjusted earnings growth in fiscal 2027, but its recovery still rests on how successfully it converts a larger backlog into cash flow.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Marimaca Copper ended September with US$126.6 million in cash and US$135.5 million in net working capital, giving the pre-revenue Chilean developer funding visibility for at least the next year. A potential US$17.3 million VAT recovery could add to that liquidity in the first half of 2027, but the Marimaca Project has not yet reached demonstrable technical feasibility or commercial viability.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
McKesson delivered a strong fiscal second quarter, with revenue up 8% and adjusted diluted EPS rising 18%. The healthcare distributor lifted its full-year adjusted EPS guidance while expanding its specialty-care portfolio through new investments and acquisitions.
Ada Torres
Ada Torres
5 Nov 2026
National Australia Bank’s FY2026 profit fell 9.1% to $6.143 billion as higher credit impairment charges and a $1.347 billion software amortisation charge outweighed stronger lending income. The dividend held at 170 cents per share, while capital buffers improved and management flagged a sharper focus on efficiency and risk control.
Victor Sage
Victor Sage
5 Nov 2026
FIS delivered a sharp third-quarter revenue increase and lifted adjusted EBITDA, but its next phase is centred on deleveraging rather than aggressive capital returns. The fintech has paused meaningful buybacks and tuck-in acquisitions while it works towards a gross leverage target of about 2.8 times.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Trimble delivered record annualized recurring revenue and a stronger-than-expected third quarter, while a US$562 million goodwill impairment keeps the headline GAAP picture complicated. The company raised no quantified comparison to its previous outlook, but issued full-year revenue and earnings ranges for 2026.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Kraft Heinz reported falling third-quarter sales, profit and volumes, but raised the low end of its full-year organic sales outlook. The company also lifted its adjusted EPS range while leaving its sharply lower adjusted operating income forecast unchanged.
Victor Sage
Victor Sage
4 Nov 2026
Cencora delivered a stronger fiscal 2026, with adjusted earnings per share rising 12.3% and quarterly profit benefiting from the OneOncology acquisition. The healthcare distributor expects another 8% to 10% increase in adjusted EPS in fiscal 2027, while reshaping its reporting structure and lifting its dividend.
Ada Torres
Ada Torres
4 Nov 2026
CVS Health plans to separate its healthcare solutions and retail pharmacy businesses by the first half of 2028, while raising its 2026 earnings and cash-flow targets. The announcement came alongside stronger third-quarter results, though management flagged elevated cost trends and potential macroeconomic pressure.
Ada Torres
Ada Torres
4 Nov 2026

Browse the archive

Full archive